A detailed history of Nantahala Capital Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 5,180,951 shares of SVRA stock, worth $16.6 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
5,180,951
Previous 5,180,951 -0.0%
Holding current value
$16.6 Million
Previous $20.9 Million 5.21%
% of portfolio
1.3%
Previous 1.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.66 - $5.34 $12.6 Million - $18.4 Million
3,443,541 Added 198.2%
5,180,951 $20.9 Million
Q1 2024

May 15, 2024

BUY
$4.19 - $5.59 $3.14 Million - $4.19 Million
749,507 Added 75.87%
1,737,410 $8.65 Million
Q4 2023

Feb 14, 2024

SELL
$3.18 - $4.9 $163,645 - $252,158
-51,461 Reduced 4.95%
987,903 $4.64 Million
Q3 2023

Nov 14, 2023

BUY
$2.97 - $3.88 $3.09 Million - $4.03 Million
1,039,364 New
1,039,364 $3.93 Million

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $365M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.